Seroprevalence Study and Cross-Sectional Survey on COVID-19 for a Plan to Reopen the University of Alicante (Spain)
Open Access
- 16 February 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (4), 1908
- https://doi.org/10.3390/ijerph18041908
Abstract
The implementation of strategies to mitigate possible cases of COVID-19 were addressed at the University of Alicante for the safe reopening of the 2020/2021 academic year. To discover the prevalence of immunity against SARS-CoV-2, a study was designed using a rapid immunoassay test (carried out between 6 and 22 July 2020), and in addition a cross-sectional survey was conducted on risk factors, symptoms, predisposition for becoming vaccinated, and sources of information about COVID-19. A random sample, stratified by students, faculty, and administrative staff, was selected. The seroprevalence found was 2.64% (39/1479; 95% CI 1.8–3.4), and the adjusted seroprevalence was 2.89% (95% CI 2.1–3.7). The average age of the students was 23.2 years old, and 47.6 years old for staff. In relation to COVID-19, the following was found: 17.7% pauci-symptomatic, 1.3% symptomatic, 5.5% contact with cases, 4.9% confined, and 0.3% PCR positive. More than 90% complied with preventive measures. The proportion willing to receive the COVID-19 vaccine was 91%. Their sources of information were the Internet (74%) and television (70.1%). They requested that the university offer information (45.1%), training (27%), and provide Personal Protective Equipment (PPE) (26.3%). Lastly, 87.9% would repeat the test. A plan was established that included the follow-up of cases and contacts, random sample testing, training courses, bimodal teaching, a specific website, and the distribution of PPE.Keywords
Funding Information
- Universidad de Alicante (BOUA April 1, 2020)
This publication has 35 references indexed in Scilit:
- Estimating the burden of SARS-CoV-2 in FranceScience, 2020
- Connecting clusters of COVID-19: an epidemiological and serological investigationThe Lancet Infectious Diseases, 2020
- “The storm has arrived”: the impact of SARS-CoV-2 on medical studentsPerspectives on Medical Education, 2020
- COVID-19: consequences for higher educationPublished by Elsevier BV ,2020
- Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-AnalysisDiagnostics, 2020
- Understanding Knowledge and Behaviors Related to CoViD–19 Epidemic in Italian Undergraduate Students: The EPICO StudyInternational Journal of Environmental Research and Public Health, 2020
- Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19mBio, 2020
- Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosisJournal of Medical Virology, 2020
- Factors associated with anal cancer screening uptake in men who have sex with men living with HIV: a cross-sectional studyEuropean Journal Of Cancer Prevention, 2020
- Estimating Prevalence Using an Imperfect TestEpidemiology Research International, 2011